Trial
NCT02499952
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Nasser Hanna, M.D.
Collaborators
Hoosier Cancer Research Network; Merck Sharp & Dohme LLC
Condition
Germ Cell Neoplasms
Intervention
Pembrolizumab
Why stopped
Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-11